Arturo Molina M.D., Chief Medical Officer at Protagonist Therapeutics, Inc (PTGX), sold 20,000 shares at $55.51 ($1.1M) on 2025-06-09, disclosed to the SEC on 2025-06-11.
Open-market sale of $1.1M PTGX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.51 | 10,000 | $555K | 49.3% |
| 2 | $57.03 | 10,000 | $570K | 50.7% |
| Total | $56.27 avg | 20,000 | $1.1M | 100% |
| Filing → |
| PTGX | SELL | 2026-01-21 | $785K | — | Filing → |
| PTGX | SELL | 2025-11-19 | $460K | — | Filing → |
| PTGX | SELL | 2025-03-14 | $3.4M | — | Filing → |